Sara Seepo

5.0k total citations
6 papers, 310 citations indexed

About

Sara Seepo is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Surgery. According to data from OpenAlex, Sara Seepo has authored 6 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 4 papers in Cancer Research and 2 papers in Surgery. Recurrent topics in Sara Seepo's work include Cancer Genomics and Diagnostics (4 papers), Testicular diseases and treatments (2 papers) and Renal cell carcinoma treatment (2 papers). Sara Seepo is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), Testicular diseases and treatments (2 papers) and Renal cell carcinoma treatment (2 papers). Sara Seepo collaborates with scholars based in United States, Poland and Singapore. Sara Seepo's co-authors include Adriana Heguy, Chandra Goparaju, Guangwu Guo, Igor Dolgalev, Michele Carbone, Matthew Meyerson, Juliann Chmielecki, Harvey I. Pass, Magdalena E. Tyburczy and Sergiusz Jóźwiak and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Sara Seepo

6 papers receiving 307 citations

Peers

Sara Seepo
Comparison fields: 5 of 40
  • Pulmonary and Respiratory Medicine 244
  • Molecular Biology 79
  • Oncology 56
  • Biotechnology 37
  • Physiology 34
Replace Sook Kyung with:
Sook Kyung South Korea
Peng-Tao Guo China
G. Hommel Germany
Sayaka Ueno Japan
Dong‐Chun Hong China
Akhila Wimalasingham United Kingdom
Hannah V. Woodcock United Kingdom
Phuong Vu Norway
N. А. Oskina Russia
Doraid Alrifai United Kingdom
Sook Kyung South Korea View profile →
Citations per field, relative to Sara Seepo
Sara Seepo · 1×
Citations per year, relative to Sara Seepo
Sara Seepo · 1×

Countries citing papers authored by Sara Seepo

Since Specialization
Citations

This map shows the geographic impact of Sara Seepo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Seepo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Seepo more than expected).

Fields of papers citing papers by Sara Seepo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Seepo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Seepo. The network helps show where Sara Seepo may publish in the future.

Co-authorship network of co-authors of Sara Seepo

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Seepo. A scholar is included among the top collaborators of Sara Seepo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Seepo. Sara Seepo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
# Work Indexed citations
1 4
2 18
3 14
4 1
5 229
6 44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026